Refresher Courses: Breast

RC 1702 - Neoadjuvant therapy of breast cancer: image-guided treatment

March 5, 08:00 - 09:00 CET

RC 1702-1
5 min
Chairperson's introduction
Erkin Aribal, Istanbul / Turkey
RC 1702-2
15 min
Current role and results of imaging methods to detect residual disease
1. To understand the various patterns of response to neoadjuvant chemotherapy (NAC) and how they appear on various imaging modalities.
2. To understand the advantages and limitations of mammography, US, and MRI in evaluating residual disease following NAC.
3. To become familiar with new technologies and the evaluation of response to NAC (US elastography and CESM).
RC 1702-3
15 min
Early response assessment and potential change of treatment: what needs to be done?
Claudette Loo, Amsterdam / Netherlands
1. To review the assessment and appearance of complete, partial, and non-response to neoadjuvant systemic therapy in breast MRI.
2. To become familiar with the influence of subtypes of breast cancer to response monitoring.
3. To understand the causes of over and underestimation of residual disease at MRI after neoadjuvant therapy.
RC 1702-4
15 min
Post-therapeutic management: is this the time to start omitting surgery?
Sara Jimenez Arranz, Madrid / Spain
1. To choose the best imaging modalities per breast cancer subtype when selecting patients for potential biopsy and the elimination of surgery.
2. To identify the optimal method of minimal invasive biopsy, including FNA versus core cut versus VACB/VAE in the post-N-acetylcysteine.
3. To analyse if the accuracy of image-guided biopsy is comparable with the gold standard surgical treatment.
4. To list the most relevant clinical trials that are omitting surgery after N-acetylcysteine.
RC 1702-5
10 min
Panel discussion: Is it possible to team up with the oncologists to adapt treatment using imaging biomarkers?

Moderators

Moderator

Mustafa Erkin Aribal

Istanbul, Turkey

Speakers

Presenter

Mustafa Erkin Aribal

Istanbul, Turkey

Presenter

Claudette Loo

Amsterdam, Netherlands

Presenter

Sara Jimenez Arranz

Madrid, Spain